Status message

Active context: kki_bg_colors_yellow

An Open-Label Extension Study of the Long-Term Safety, Tolerability and Efficacy of Drisapersen in US And Canadian Subjects with Duchenne Muscular Dystrophy

This is a phase III, multicenter, open-label, uncontrolled extension study in male subjects with DMD open to eligible US who previously participated in a GSK drisapersen study.

Publications

Read inspiring stories, news and updates about the Institute's patient care, research, special education, professional training, and community programs.